Collectively, substantial evidence links eosinophils with IBD activity: they are often increased in blood and gut during flares, carry activation markers, release toxic granule contents correlated with disease, and engage in crosstalk with the type 2 immune axis (IL-5, eotaxin). This evidence concerns the gene CCL11 and inflammatory bowel disease.